Oncology biotech Immix Biopharma files for a $25 million IPOSeptember 17, 2021Immix Biopharma, a Phase 1b/2a […]
Oncodisc To Combine With PAVmed Subsidiary Veris Health To Advance Development Of Next-Generation Intelligent Implantable Remote […]